Fulvestrant Rompharm

Fulvestrant Rompharm is an intramuscular medication used for hormone receptor-positive breast cancer. This estrogen receptor antagonist is manufactured by S.C. Rompharm Company S.R.L. in the EU.

Fulvestrant Rompharm is primarily used in the treatment of hormone receptor-positive breast cancer. It works by blocking the effects of estrogen in the body, which can help slow the growth of certain types of breast cancer cells. This medication is often considered for postmenopausal women with advanced breast cancer.

Common effects of Fulvestrant Rompharm may include injection site reactions, such as pain, swelling, or redness. Some individuals might experience fatigue, nausea, or headaches. These effects vary and are not experienced by everyone.

Fulvestrant Rompharm should be administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before starting this treatment. Regular monitoring may be required during therapy.

Fulvestrant Rompharm may interact with other medications, including those that affect liver enzymes. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should be discussed with a healthcare professional.